DR REDDYS LABORATORIES LTD

Global pharma firm providing affordable generics, APIs, and medicines to patients worldwide.

RDY | US

Overview

Corporate Details

ISIN(s):: US2561352038
LEI:
Country:: United States of America
Address:: 8-2-337, ROAD NO.3 BANJARA HILLS, HYDERABAD
Website:: https://www.drreddys.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Dr. Reddy's Laboratories Ltd., established in 1984, is an integrated global pharmaceutical company. The firm develops, manufactures, and markets a wide range of pharmaceutical products. Its core business segments include Global Generics, Pharmaceutical Services, and Active Ingredients (PSAI). The company's portfolio comprises over 190 medications, 60 active pharmaceutical ingredients (APIs), diagnostic kits, and products in critical care and biotechnology. Dr. Reddy's focuses on key therapeutic areas such as gastrointestinal, cardiovascular, pain management, oncology, neurology, and anti-infectives. Driven by the purpose "Good Health Can't Wait," the company aims to provide affordable and innovative medicines to patients worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all DR REDDYS LABORATORIES LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DR REDDYS LABORATORIES LTD

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for DR REDDYS LABORATORIES LTD via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Immix Biopharma, Inc. Developing safer cell therapies for AL Amyloidosis and hematologic malignancies.	United States of America	IMMX
IMMUCELL CORP /DE/ Develops biotech health products for disease prevention in dairy and beef cattle.	United States of America	ICCC
Immuneering Corp Clinical-stage oncology firm using bioinformatics to develop oral MEK inhibitors for solid tumors.	United States of America	IMRX
ImmuneOncia Therapeutics, Inc. A biopharma firm developing immune checkpoint inhibitors for cancer immunotherapy.	South Korea	424870
ImmunityBio, Inc. Develops immunotherapies activating the immune system to fight cancer and infectious diseases.	United States of America	IBRX
Immuno-Biological Laboratories Co., Ltd. Develops and supplies immunological reagents and diagnostics for research and drug discovery.	Japan	4570
Immunocore Holdings plc Pioneering TCR bispecific immunotherapies for cancer, infectious, and autoimmune diseases.	United States of America	IMCR
Immunome Inc. Develops targeted oncology therapies, like ADCs, for cancers with high unmet needs.	United States of America	IMNM
Immunovant, Inc. Developing novel, FcRn-targeted therapies for people with autoimmune diseases.	United States of America	IMVT
Immuron Ltd Develops oral antibodies from bovine colostrum for digestive and immune health.	United States of America	IMRN